Clinical trials in Russian Federation

5,492 studies list at least one site in Russian Federation. 240 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-06-22.

Get an email when these change. Save the studies in Russian Federation recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 4,161
Terminated: 527
Status unknown: 439
Recruiting: 204
Active, not recruiting: 64
Withdrawn: 33

Phase

Phase 3: 2,564
Phase 2: 1,308
Phase 4: 336
Phase 1: 335
Early Phase 1: 6

Most studied here

Who runs them

Novartis Pharmaceuticals (280) · GlaxoSmithKline (244) · Hoffmann-La Roche (225) · AstraZeneca (207) · Pfizer (173) · Sanofi (158) · Boehringer Ingelheim (142) · Bristol-Myers Squibb (119)

Studies

Recruiting first, then most recently updated. Showing 50 of 5,492 — search for more.